Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Study protocol

The eCALM Trial-eTherapy for cancer appLying mindfulness: online mindfulness-based cancer recovery program for underserved individuals living with cancer in Alberta: protocol development for a randomized wait-list controlled clinical trial

Authors: Kristin A Zernicke, Tavis S Campbell, Michael Speca, Kelley McCabe-Ruff, Steven Flowers, Dale A Dirkse, Linda E Carlson

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

Elevated stress can exacerbate cancer symptom severity, and after completion of primary cancer treatments, many individuals continue to have significant distress. Mindfulness-Based Cancer Recovery (MBCR) is an 8-week group psychosocial intervention consisting of training in mindfulness meditation and yoga designed to mitigate stress, pain, and chronic illness. Efficacy research shows face-to-face (F2F) MBCR programs have positive benefits for cancer patients; however barriers exist that impede participation in F2F groups. While online MBCR groups are available to the public, none have been evaluated. Primary objective: determine whether underserved patients are willing to participate in and complete an online MBCR program. Secondary objectives: determine whether online MBCR will mirror previous efficacy findings from F2F MBCR groups on patient-reported outcomes.

Method/design

The study includes cancer patients in Alberta, exhibiting moderate distress, who do not have access to F2F MBCR. Participants will be randomized to either online MBCR, or waiting for the next available group. An anticipated sample size of 64 participants will complete measures online pre and post treatment or waiting period. Feasibility will be tracked through monitoring numbers eligible and participating through each stage of the protocol.

Discussion

47 have completed/completing the intervention. Data suggest it is possible to conduct a randomized waitlist controlled trial of online MBCR to reach underserved cancer survivors.

Trial registration

Clinical Trials.gov Identifier: NCT01476891
Appendix
Available only for authorised users
Literature
1.
Walker MS, Zona DM, Fisher EB: Depressive symptoms after lung cancer surgery: their relation to coping style and social support. Psychooncology. 2006, 15: 684-693. 10.1002/pon.997.CrossRefPubMed
2.
Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PL: Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer. 2002, IS: 329-336.CrossRef
3.
Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, McRae JH, Martin M, Pelletier G, Robinson J, Simpson JSA, Tillotson L, Bultz BD: High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004, 90: 2297-2304.PubMedPubMedCentral
4.
Carlson LE, Bultz BD: Cancer distress screening: Needs, methods and models. J Psychosom Res. 2003, 55: 403-409. 10.1016/S0022-3999(03)00514-2.CrossRefPubMed
5.
Sellick SM, Edwardson AD: Screening new cancer patients for psychological distress using the hospital anxiety and depression scale. Psychooncology. 2007, 16: 534-542. 10.1002/pon.1085.CrossRefPubMed
6.
Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S: The prevalence of psychological distress by cancer site. Psychooncology. 2001, 10: 19-28. 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6.CrossRefPubMed
7.
Bultz BD, Carlson LE: Emotional distress: The 6th vital sign in cancer care. Psychooncology. 2006, 15: 93-95. 10.1002/pon.1022.CrossRefPubMed
8.
Kangas M, Henry J, Bryant R: The relationship between acute stress disorder and posttraumatic stress disorder following cancer. J Consult Clin Psychol. 2005, 73: 360-364.CrossRefPubMed
9.
Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC: Psychiatric disorder in women with early stage and advanced breast cancer: A comparative analysis. Aust N Z J Psychiatry. 2004, 38: 320-326. 10.1080/j.1440-1614.2004.01358.x.CrossRefPubMed
10.
Carlson LE, Labelle LE, Garland SN, Hutchins ML, Birnie K: Mindfulness-based interventions in oncology. Clinical handbook of mindfulness. Edited by: Didonna F. 2009, New York, NY: Springer, 383-404.CrossRef
11.
Labelle LE, Campbell TS, Carlson LE: Mindfulness-based stress reduction in oncology: Evaluating mindfulness and rumination as mediators of change in depressive symptoms. Mindfulness. 2010, 1: 28-40. 10.1007/s12671-010-0005-6.CrossRef
12.
Kabat-Zinn J: Full catastrophe living: Using the wisdom of your body and mind to face stress, pain and illness. 1990, New York: Bantam Doubleday Dell Publishing Group, Inc
13.
Carlson LE, Speca M: Managing daily and long-term stress. Handbook of Cancer Survivorship. Edited by: Feurestein M. 2007, New York, NY: Springer, 339-360.CrossRef
14.
Lamanque P, Daneault S: Does meditation improve the quality of life for patients living with cancer?. Can Fam Physician/Medecin De Famille Canadien. 2006, 52: 474-475.PubMed
15.
Mackenzie MJ, Carlson LE, Speca M: Mindfulness-based stress reduction (MBSR) in oncology: Rationale and review. Evid Base Integr Med. 2005, 2: 139-145. 10.2165/01197065-200502030-00005.CrossRef
16.
Matchim Y, Armer J: Measuring the psychological impact of mindfulness meditation on health among patients with cancer: A literature review. Oncol Nurs Forum. 2007, 34: 1059-1066. 10.1188/07.ONF.1059-1066.CrossRefPubMed
17.
Ott MJ, Norris RL, Bauer-Wu SM: Mindfulness meditation for oncology patients: A discussion and critical review. Integr Cancer Ther. 2006, 5: 98-108. 10.1177/1534735406288083.CrossRefPubMed
18.
Smith JE, Richardson J, Hoffman C, Pilkington K: Mindfulness-based stress reduction as supportive therapy in cancer care: Systematic review. J Adv Nurs. 2005, 52: 315-327. 10.1111/j.1365-2648.2005.03592.x.CrossRefPubMed
19.
Shigaki CL, Glass B, Schopp LH: Mindfulness-based stress reduction in medical settings. J Clin Psychol Med Settings. 2006, 13: 209-216. 10.1007/s10880-006-9033-8.CrossRef
20.
Ledesma D, Kumano H: Mindfulness-based stress reduction and cancer: A meta-analysis. Psychooncology. 2008, 18: 571-579.CrossRef
21.
Brown KW, Ryan RM: The benefits of being present: Mindfulness and its role in psychological well-being. J Personal Soc Psychol. 2003, 84: 822-848.CrossRef
22.
Carlson LE, Ursuliak Z, Goodey E, Angen M, Speca M: The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Support Care Cancer. 2001, 9: 112-123. 10.1007/s005200000206.CrossRefPubMed
23.
Carlson LE, Garland SN: Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005, 12: 278-285. 10.1207/s15327558ijbm1204_9.CrossRefPubMed
24.
Garland SM, Carlson LE, Cook S, Lansdell L, Speca M: A non-randomized comparison of mindfulness-based stress reduction and healing arts programs for facilitating post-traumatic growth and spirituality in cancer outpatients. Support Care Cancer. 2007, 15: 949-961. 10.1007/s00520-007-0280-5.CrossRefPubMed
25.
Shapiro SL, Bootzin RR, Figueredo AJ, Lopez AM, Schwartz GE: The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: An exploratory study. J Psychosom Res. 2003, 54: 85-91. 10.1016/S0022-3999(02)00546-9.CrossRefPubMed
26.
Speca M, Carlson LE, Goodey E, Angen M: A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 2000, 62: 613-622.CrossRefPubMed
27.
Tacon AM, Caldera YM, Ronaghan C: Mindfulness-based stress reduction in women with breast cancer. Fam Syst Health. 2004, 22: 193-203.CrossRef
28.
Tacon AM: Mindfulness effects on symptoms of distress in women with cancer. Journal of Cancer Pain and Symptom Palliation. 2006, 2: 17-22. 10.1300/J427v02n01_04.CrossRef
29.
Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M, Goodman M, Cox CE, Kip KE: Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology. 2009, 18: 1261-1272. 10.1002/pon.1529.CrossRefPubMed
30.
Carlson LE, Speca M, Faris P, Patel KD: One year prepost intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun. 2007, 21: 1038-1049. 10.1016/j.bbi.2007.04.002.CrossRefPubMed
31.
Carlson LE, Speca M, Patel KD, Goodey E: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinolog. 2004, 29: 448-474. 10.1016/S0306-4530(03)00054-4.CrossRef
32.
33.
Bargh JA, McKenna KYA: The internet and social life. Annu Rev Psychol. 2004, 55: 573-590. 10.1146/annurev.psych.55.090902.141922.CrossRefPubMed
34.
Barak A, Hen L, Boniel-Nissim M, Shapira N: A comprehensive review and a meta-analysis of the effectiveness of Internet-based psychotherapeutic interventions. J Technol Hum Serv. 2008, 26: 109-160. 10.1080/15228830802094429.CrossRef
35.
Gardner-Nix J, Backman S, Barbati J, Grummitt J: Evaluating distance education of mindfulness-based meditation programme for chronic pain management. J Telemed Telecare. 2008, 14: 88-92. 10.1258/jtt.2007.070811.CrossRefPubMed
36.
Owen JE, Klapow JC, Roth DL, Shuster JL, Bellis J, Meredith R, Tucker DC: Randomized pilot of a self-guided internet coping group for women with early-stage breast cancer. Ann Behav Med. 2005, 30: 54-64. 10.1207/s15324796abm3001_7.CrossRefPubMed
37.
Carlson LE, Speca M: Mindfulness-based cancer recovery: A step-by-step MBSR approach to help you cope with treatment and reclaim your life. 2010, Oakland, CA: New Harbinger Publications, Inc
38.
National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: Distress management. Version 2. 2013, Fort Washington, PA
39.
Jacobsen PB, Donovan KA, Trask PC, Fleishman SB, Zabora J, Baker F, Holland JC: Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005, 103: 1494-1502. 10.1002/cncr.20940.CrossRefPubMed
40.
Dolbeault S, Mignot V, Gauvain-Piquard A, Mandereau L, Asselain B, Medioni J: Evaluation of psychological distress and quality of life in French cancer patients: validation of the French version of the memorial distress thermometer. Psychooncology. 2003, 12: S225-
41.
McNair DA, Lorr M, Droppelman LF: Profile of mood states. 1971, San Diego: Educational and Industrial Testing Service
42.
Carlson LE, Thomas BC: Development of the Calgary Symptoms of Stress Inventory (C-SOSI). Int J Behav Med. 2007, 14: 249-256. 10.1007/BF03003000.CrossRefPubMed
43.
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D: Measuring spiritual well-being in people with cancer: The functional assessment of chronic illness therapy–spiritual well-being scale (FACIT-sp). Ann Behav Med. 2002, 24: 49-58. 10.1207/S15324796ABM2401_06.CrossRefPubMed
44.
Tedeschi RG, Calhoun LG: The posttraumatic growth inventory: Measuring the positive legacy of trauma. J Trauma Stress. 1996, 9: 455-471. 10.1002/jts.2490090305.CrossRefPubMed
45.
Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L: Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006, 13: 27-45. 10.1177/1073191105283504.CrossRefPubMed
46.
Carlson LE, Speca M, Patel KD, Goodey E: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003, 65: 571-581. 10.1097/01.PSY.0000074003.35911.41.CrossRefPubMed
47.
Dattalo P: Determining sample size: Balancing power, precision and practicality – Pocket guide to social work research methods. 2008, New York: Oxford University PressCrossRef
Metadata
Title
The eCALM Trial-eTherapy for cancer appLying mindfulness: online mindfulness-based cancer recovery program for underserved individuals living with cancer in Alberta: protocol development for a randomized wait-list controlled clinical trial
Authors
Kristin A Zernicke
Tavis S Campbell
Michael Speca
Kelley McCabe-Ruff
Steven Flowers
Dale A Dirkse
Linda E Carlson
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-34

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue

Research article

Dracaena arborea alleviates ultra-structural spermatogenic alterations in streptozotocin-induced diabetic rats

Research article

Oral supplementation with areca-derived polyphenols attenuates food allergic responses in ovalbumin-sensitized mice

Research article

In vitro neuroprotective potential of four medicinal plants against rotenone-induced toxicity in SH-SY5Y neuroblastoma cells

Research article

Chemical composition and antioxidant capacities of phytococktail extracts from trans-Himalayan cold desert

Research article

Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5

Research article

Cytotoxicity of Elaoephorbia drupifera and other Cameroonian medicinal plants against drug sensitive and multidrug resistant cancer cells